Associate Professor, Pediatrics, University of Cincinnati College of Medicine

Pediatric Hematology & Oncology

Parinda A. Mehta, MB is an expert in the field of Pediatric Hematology & Oncology. She went to SUNY Upstate Medical University. Parinda Mehta is a published physician. She published 37 publications, including: 'A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation.'

Publications

---

• Genotype-Directed Dosing Leads to Optimized Voriconazole Levels in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.
• A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation.
• Skin and Mucosal Human Papillomavirus Seroprevalence in Persons with Fanconi Anemia.
• High risk HPV E6 protein promotes reprogramming of Fanconi Anemia patient cells through repression of p53 but does not allow for sustained growth of iPSC.
• The successful use of alemtuzumab for treatment of steroid-refractory acute Graft-versus-host disease in pediatric patients.
• Concomitant inactivation of Foxo3a and Fancc or Fancd2 reveals a two-tier protection from oxidative stress-induced hydrocephalus.
• Deletion of Fanca or Fancd2 dysregulates Treg in mice.
• An Intermediate Alemtuzumab Schedule Reduces the Incidence of Mixed Chimerism Following Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Hemophago...
• Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome.
• Hematopoietic cell transplantation for thalassemia: a global perspective BMT tandem meeting 2013.
• The fanconi Anemia pathway limits human papillomavirus replication.
• Fanconi Anemia Links Reactive Oxygen Species to Insulin Resistance and Obesity.
• Hematopoietic cell transplantation for nonmalignant Disorders.
• Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission.
• The clinical phenotype of children with Fanconi Anemia caused by biallelic FANCD1/BRCA2 mutations.
• Impaired immune function in children with Fanconi anaemia.
• Blood, and Not Urine, BK Viral Load Predicts Renal Outcome in Children with Hemorrhagic Cystitis following Hematopoietic Stem Cell Transplantation.
• Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplanta...
• Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi Anemia.
• Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.
• Alternate-day micafungin antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic study.
• Pediatric acute lymphoblastic leukemia: is there still a role for transplant?
• FAS promoter polymorphism: outcome of childhood acute myeloid leukemia. A children's oncology group report.
• Chemotherapy for myeloid malignancy in children with Fanconi Anemia.
• Pre-transplant minimal residual Disease in children with acute lymphoblastic leukemia.
• Pharmacogenetics of acute lymphoblastic leukemia.
• Successful reduced-intensity bone marrow transplantation in a patient with bone marrow failure associated with Seckel syndrome.
• Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.
• XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children''s Oncology Group report.
• Interleukin-1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia.
• Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome.
• Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: a report from the Children''s Oncology Group.
• Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.
• Allogeneic transplantation for childhood ALL.
• DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children''s Oncology Group.
• Risk factors for sternal wound and other infections in pediatric cardiac surgery patients.

Schools

---

• Seth GS Medical College Maharashtra University Of Health Sciences

Procedures Preformed

---

• HPC Transplantation (Stem Cell Transplant)
• Plasmapheresis

Conditions Treated

---

• Anemia
• Graft vs Host Disease
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• View All

Doctors Specialties

---

• Pediatric Hematology
• Oncology

Accepted Insurances

---

Education

---

• Cincinnati Children's Hospital Medical Center
• SUNY Upstate Medical University
• Seth G.S. Medical College

Hospital

---

• Cincinnati Children's Hospital Medical Center

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Alexandra H. Filipovich, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Brian K. Turpin, DO This Doctor is OpenDoctor Recommended.
	Dr. Jennifer L. Mangino, MD This Doctor is OpenDoctor Recommended.
	Dr. Rajaram Nagarajan, MD This Doctor is OpenDoctor Recommended.
	Dr. Patrick T. McGann, MD This Doctor is OpenDoctor Recommended.
	Dr. Karen C. Burns, MD This Doctor is OpenDoctor Recommended.
	Dr. Theodosia A. Kalfa, MD This Doctor is OpenDoctor Recommended.
	Dr. John Perentesis, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog